These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 14059162)

  • 1. [ACTION OF DOPA AND MONOAMINE OXIDASE INHIBITION BY IPRONIAZID ON THE BRAIN].
    MONNIER M; GRABER S
    Schweiz Arch Neurol Neurochir Psychiatr; 1963; 92():410-4. PubMed ID: 14059162
    [No Abstract]   [Full Text] [Related]  

  • 2. Regional inhibition of brain monoamine oxidase measured by microscopic photometry.
    Eadie MJ; Tyrer JH; Kukums JR
    Proc Aust Assoc Neurol; 1968; 5(3):503-5. PubMed ID: 5709976
    [No Abstract]   [Full Text] [Related]  

  • 3. [PROSPECTIVES FOR THE USE OF MONOAMINE OXIDASE INHIBITORS IN PEDIATRICS].
    ANSANELLI V
    Pediatria (Napoli); 1964; 72():133-9. PubMed ID: 14163248
    [No Abstract]   [Full Text] [Related]  

  • 4. [THE ROLE OF CATECHOLAMINES IN THE CONTROL OF HYPOTHALAMIC NEUROSECRETION. EFFECTS OF RESERPINE COMPOUNDS, MONOAMINE OXIDASE INHIBITORS AND D-1 DOPA 5-HTP DECARBOXYLASE INHIBITORS].
    CAHN J; HEROLD M
    Agressologie; 1964; 5():451-63. PubMed ID: 14192331
    [No Abstract]   [Full Text] [Related]  

  • 5. [THE ROLE OF CATECHOLAMINES IN THE CONTROL OF HYPOTHALAMIC NEUROSECRETION. EFFECTS OF RESERPINE, A MONOAMINE OXIDASE INHIBITOR AND DIFFERENT D-1 DOPA 5-HTP DECARBOXYLASE INHIBITORS].
    SOULAIRAC A; SOULAIRAC ML
    Agressologie; 1964; 5():465-71. PubMed ID: 14192332
    [No Abstract]   [Full Text] [Related]  

  • 6. Analgesic effect of some monoamine oxidase inhibitors.
    Jauhari AC; Bapat SK
    Indian J Physiol Pharmacol; 1971 Jan; 15(1):21-6. PubMed ID: 5122772
    [No Abstract]   [Full Text] [Related]  

  • 7. [Inhibition of monamine oxidase activity by substituted azetidines].
    SCHIATTI P; SELVA D
    Boll Soc Ital Biol Sper; 1961 Dec; 37():1432-6. PubMed ID: 13991650
    [No Abstract]   [Full Text] [Related]  

  • 8. Alterations of monoamine content by decaborane after monoamine oxidase inhibition by iproniazid. SAM-TR-67-72.
    Merritt JH; Sulkowski TS
    Tech Rep SAM-TR; 1967 Jul; ():1-6. PubMed ID: 5301200
    [No Abstract]   [Full Text] [Related]  

  • 9. [THE EFFECT OF IPRONIAZID AND PHENYZINE OF 5-HYDOXYTRYPTOPHAN DECARBOXYLASE].
    UTESHEV BS
    Farmakol Toksikol; 1964; 27():293-5. PubMed ID: 14238785
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental animal research on the mechanism of the narcosis-shortening action of monoamine oxidase inhibitors].
    WESTERMANN E; STOCK K
    Chemotherapia (Basel); 1962; 4():329-39. PubMed ID: 14006333
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preliminary tests of the action of an MAO inhibitor (Iproniazid) on iris motility].
    Balacco-Gabrieli C
    Boll Soc Ital Biol Sper; 1971 Jan; 47(2):36-8. PubMed ID: 5088816
    [No Abstract]   [Full Text] [Related]  

  • 12. [INHIBITION OF MONOAMINE OXIDASE AND POTENTIATION OF EXPERIMENTAL SLEEP].
    LECHAT P; LEMEIGNAN M
    Med Exp Int J Exp Med; 1964; 10():56-66. PubMed ID: 14121410
    [No Abstract]   [Full Text] [Related]  

  • 13. [ON BLOOD COAGULATION CHANGES AND THE ANTICOAGULANT EFFECT OF MONOAMINE OXIDASE INHIBITORS].
    HRDINA P; KOVALCIK V
    Cas Lek Cesk; 1963 May; 102():574-9. PubMed ID: 14051515
    [No Abstract]   [Full Text] [Related]  

  • 14. [PROBLEMS IN INTERPRETATION OF THE MECHANISM OF EFFECT OF PSYCHOPHARMACOLOGICAL AGENTS].
    VITEK V; RYSANEK K
    Act Nerv Super (Praha); 1964; 6():160-5. PubMed ID: 14164145
    [No Abstract]   [Full Text] [Related]  

  • 15. Actions of levodopa on the blood pressure of conscious rabbits.
    Calne DB; Reid JL
    Br J Pharmacol; 1973 Jun; 48(2):194-7. PubMed ID: 4733725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relations between inhibition of cerebral monoamine oxidase in mice and the pyridoxal-5-phosphate-monoamine oxidase inhibitor pharmacological antagonism in the presence of 3,4-dihydroxyphenylalanine].
    Lévy J; Michel-Ber E
    J Physiol (Paris); 1965; 57(4):475-83. PubMed ID: 5848057
    [No Abstract]   [Full Text] [Related]  

  • 17. Anomalous actions of monoamine oxidase inhibitors.
    PSCHEIDT GR
    Ann N Y Acad Sci; 1963 Jul; 107():1057-67. PubMed ID: 13972407
    [No Abstract]   [Full Text] [Related]  

  • 18. The inhibitory action of L-dihydroxyphenylalanine (L-dopa) in the presence of a monoamine oxidase inhibitor on protein synthesis in vivo and the partial amelioration of this by methionine supplementation.
    Bone AH; Taufek HR
    Biochem J; 1980 Nov; 192(2):703-7. PubMed ID: 7236233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological estimation of the intensity and duration of action of monoamine oxidase inhibitors.
    PLUMMER AJ; FURNESS PA
    Ann N Y Acad Sci; 1963 Jul; 107():865-77. PubMed ID: 13944106
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic action of a monoamine oxidase inhibitor, marsilid (iproniazid), on depressive states].
    DICK P
    Schweiz Med Wochenschr; 1959 Dec; 89():1288-91. PubMed ID: 13816578
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.